AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2023
Jun 3, 2023
34428_dirs_2023-06-02_01b8fa4d-a06c-407d-8d41-af2cd4c95d4b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-06-01
Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-01 | Common Stock | S | 393 | $11.48 | Disposed | 259500 | Direct |
| 2023-06-01 | Common Stock | S | 692 | $11.48 | Disposed | 258808 | Direct |
| 2023-06-01 | Common Stock | S | 1760 | $11.48 | Disposed | 257048 | Direct |
Footnotes
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
More from Pulmonx Corp
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Call Transcript
2026
Jun 4
Regulatory Filings
2026
May 18
Call Transcript
2026
May 12
Interim / Quarterly Report
2026
May 4
Call Transcript
2026
Apr 29
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Call Transcript
2026
Mar 4